Suvi‐Katri Leivonen

3.8k total citations
59 papers, 2.7k citations indexed

About

Suvi‐Katri Leivonen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Suvi‐Katri Leivonen has authored 59 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 27 papers in Cancer Research and 25 papers in Oncology. Recurrent topics in Suvi‐Katri Leivonen's work include MicroRNA in disease regulation (19 papers), Lymphoma Diagnosis and Treatment (19 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Suvi‐Katri Leivonen is often cited by papers focused on MicroRNA in disease regulation (19 papers), Lymphoma Diagnosis and Treatment (19 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Suvi‐Katri Leivonen collaborates with scholars based in Finland, Norway and Sweden. Suvi‐Katri Leivonen's co-authors include Veli‐Matti Kähäri, Merja Perälä, Olli Kallioniemi, Kristine Kleivi Sahlberg, Rami Mäkelä, Sirpa Leppä, Anne‐Lise Børresen‐Dale, Päivi Östling, Lari Häkkinen and Pekka Kohonen and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Suvi‐Katri Leivonen

54 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suvi‐Katri Leivonen Finland 27 1.9k 1.4k 604 360 325 59 2.7k
Baocun Sun China 38 2.1k 1.2× 1.3k 0.9× 974 1.6× 267 0.7× 149 0.5× 64 2.9k
Nabendu Pore United States 17 1.4k 0.8× 1.1k 0.8× 614 1.0× 244 0.7× 139 0.4× 26 2.3k
Jianfei Huang China 31 1.6k 0.9× 866 0.6× 761 1.3× 324 0.9× 178 0.5× 96 2.5k
Atsushi Kasamatsu Japan 34 1.9k 1.0× 821 0.6× 948 1.6× 438 1.2× 161 0.5× 133 3.0k
Xueshan Qiu China 32 2.1k 1.1× 1.1k 0.8× 948 1.6× 431 1.2× 266 0.8× 145 3.4k
Zhe Lei China 26 1.9k 1.0× 1.4k 1.0× 484 0.8× 199 0.6× 161 0.5× 86 2.5k
Daizo Koinuma Japan 35 2.4k 1.3× 754 0.5× 1.2k 1.9× 359 1.0× 216 0.7× 67 3.3k
Pierlorenzo Pallante Italy 34 2.9k 1.6× 2.1k 1.5× 577 1.0× 285 0.8× 213 0.7× 83 3.9k
Dario Palmieri United States 30 1.8k 1.0× 1.2k 0.8× 609 1.0× 212 0.6× 107 0.3× 62 2.6k
Sabrina Battista Italy 28 2.0k 1.1× 1.2k 0.8× 447 0.7× 254 0.7× 182 0.6× 46 2.9k

Countries citing papers authored by Suvi‐Katri Leivonen

Since Specialization
Citations

This map shows the geographic impact of Suvi‐Katri Leivonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suvi‐Katri Leivonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suvi‐Katri Leivonen more than expected).

Fields of papers citing papers by Suvi‐Katri Leivonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suvi‐Katri Leivonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suvi‐Katri Leivonen. The network helps show where Suvi‐Katri Leivonen may publish in the future.

Co-authorship network of co-authors of Suvi‐Katri Leivonen

This figure shows the co-authorship network connecting the top 25 collaborators of Suvi‐Katri Leivonen. A scholar is included among the top collaborators of Suvi‐Katri Leivonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suvi‐Katri Leivonen. Suvi‐Katri Leivonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leivonen, Suvi‐Katri, Teijo Pellinen, Marja‐Liisa Karjalainen‐Lindsberg, et al.. (2025). Characterization of cancer‐associated fibroblasts and their spatial architecture reveals heterogeneity and survival associations in classic Hodgkin lymphoma. HemaSphere. 9(5). e70145–e70145.
2.
3.
Leivonen, Suvi‐Katri, et al.. (2023). Intra-patient evolution of tumor microenvironment in the pathogenesis of treatment-naïve metastatic melanoma patients. Acta Oncologica. 62(9). 1008–1013. 1 indexed citations
4.
Leivonen, Suvi‐Katri, et al.. (2022). Low lymphocyte‐to‐monocyte ratio predicts poor outcome in high‐risk aggressive large B‐cell lymphoma. SHILAP Revista de lepidopterología. 3(3). 681–687. 4 indexed citations
5.
Leivonen, Suvi‐Katri, Maja Ludvigsen, Harald Holte, et al.. (2021). Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma. Cancers. 13(3). 398–398. 18 indexed citations
6.
Autio, Matias, Suvi‐Katri Leivonen, Oscar Brück, et al.. (2021). Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment. Clinical Cancer Research. 28(4). 781–792. 35 indexed citations
7.
Aure, Miriam R. R., Kristín Jónsdóttir, Suvi‐Katri Leivonen, et al.. (2021). miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer. PLoS Computational Biology. 17(2). e1008608–e1008608. 4 indexed citations
8.
Leivonen, Suvi‐Katri, Marja‐Liisa Karjalainen‐Lindsberg, Fong Chun Chan, et al.. (2021). Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients. Blood Advances. 6(6). 1919–1931. 11 indexed citations
9.
Leivonen, Suvi‐Katri, et al.. (2021). Testicular Diffuse Large B-Cell Lymphoma—Clinical, Molecular, and Immunological Features. Cancers. 13(16). 4049–4049. 15 indexed citations
10.
Leivonen, Suvi‐Katri, Oscar Brück, Marja‐Liisa Karjalainen‐Lindsberg, et al.. (2020). Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma. Cancers. 12(4). 877–877. 35 indexed citations
11.
Pellinen, Teijo, et al.. (2020). Adverse prognostic impact of regulatory T‐cells in testicular diffuse large B‐cell lymphoma. European Journal Of Haematology. 105(6). 712–721. 10 indexed citations
12.
Alkodsi, Amjad, Alejandra Cervera, Kaiyang Zhang, et al.. (2019). Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes. Leukemia. 33(11). 2662–2672. 22 indexed citations
13.
Leivonen, Suvi‐Katri, Amjad Alkodsi, Alejandra Cervera, et al.. (2017). MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma. Blood Cancer Journal. 7(12). 654–654. 28 indexed citations
14.
Enerly, Espen, Israel Steinfeld, Kristine Kleivi Sahlberg, et al.. (2013). Correction: miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors. PLoS ONE. 8(9). 1 indexed citations
15.
Leivonen, Suvi‐Katri, Kristine Kleivi Sahlberg, Rami Mäkelä, et al.. (2013). High‐throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth. Molecular Oncology. 8(1). 93–104. 146 indexed citations
16.
Pollari, Sirkku, Suvi‐Katri Leivonen, Merja Perälä, et al.. (2012). Identification of MicroRNAs Inhibiting TGF-β-Induced IL-11 Production in Bone Metastatic Breast Cancer Cells. PLoS ONE. 7(5). e37361–e37361. 71 indexed citations
17.
Östling, Päivi, Suvi‐Katri Leivonen, Anna Aakula, et al.. (2011). Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells. Cancer Research. 71(5). 1956–1967. 227 indexed citations
18.
Leivonen, Suvi‐Katri, Anne Rokka, Päivi Östling, et al.. (2011). Identification of miR-193b Targets in Breast Cancer Cells and Systems Biological Analysis of Their Functional Impact. Molecular & Cellular Proteomics. 10(7). M110.005322–M110.005322. 67 indexed citations
19.
Greco, Dario, et al.. (2011). Human Papillomavirus 16 E5 Modulates the Expression of Host MicroRNAs. PLoS ONE. 6(7). e21646–e21646. 83 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Baocun Sun Breakdown of academic impact, for papers by Nabendu Pore Breakdown of academic impact, for papers by Jianfei Huang Breakdown of academic impact, for papers by Atsushi Kasamatsu Breakdown of academic impact, for papers by Xueshan Qiu Breakdown of academic impact, for papers by Zhe Lei Breakdown of academic impact, for papers by Daizo Koinuma Breakdown of academic impact, for papers by Pierlorenzo Pallante Breakdown of academic impact, for papers by Dario Palmieri Breakdown of academic impact, for papers by Sabrina Battista
Rankless by CCL
2026